Table 4.
Duration and Dosage of Services & Technology
| Part. # | Duration of Prior ABA Services (months) | Dosage/week (hours) In‐person | Dosage/week (hours) All Telehealth | Latency (days) | Technology Device |
|---|---|---|---|---|---|
| 1 a | 25 | 15.75 | 5 | 30 b | Smartphone, Computer |
| 2 | 30 | 5 | 5 | 4 | Tablet |
| 3 a | 9 | 20 | 10 | 4 | Smartphone |
| 4 | 5 | 18 | 15 | 14 b | Computer |
| 5 a | 10 | 15 | 15 | 4 | Tablet |
| 6 | 14 | 10 | 10 | 1 | Tablet |
| 7 | 8 | 10 | 10 | 4 | Smartphone |
| 8 | 40 | 9 | 5 | 55 d | Smartphone, Computer |
| 9 | 14 | 0 | 10 | 10 | Tablet |
| 10 | 36 | 9 | 9 | 11 | Computer |
| 11 | 11 | 10 | 10 | 0 | Tablet |
| 12 | 24 | 9 | 9 | 16 | Tablet |
| 13 a | 12 | 25 | 15 | 16 b | Tablet |
| 14 | 36 | 8 | 10 c | 0 | Smartphone |
| 15 | 24 | 13 | 18 | 0 | Computer |
| 16 | 32 | 9 | 9 | 0 | Tablet |
| 17 | 5 | 18 | 18 | 2 | Computer |
Note. Part. = Participant
a
Participant did not demonstrate all the CASP Suggested Participant Appropriateness Indicators.
b
The family or RBT had possible exposure to COVID‐19 and a14‐day quarantine was initiated.
c
Participant was receiving in‐person and direct telehealth services (i.e., telehealth services were implemented as part of the participant's contingency plan to promote continuity of care in the event of quarantine).
d
The participant was located in a community with an extreme provider shortage prior to COVID‐19. Services were only re‐initiated due to the ability to provide direct telehealth services as a local technician was still not available.